These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2989227)

  • 1. The proliferative immune response to autologous Epstein-Barr virus-transformed lymphoblastoid cells. I. Studies with HLA haplotype loss variants demonstrate a role for MHC-linked genes.
    Reitnauer PJ; DeMars R; Sondel PM
    Hum Immunol; 1985 Jul; 13(3):177-91. PubMed ID: 2989227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential antigen presentation by heat-treated peripheral blood mononuclear cells and Epstein-Barr virus-transformed lymphoblastoid cell lines (EBV-LCL): heated EBV-LCL present alloantigen and soluble antigen but are deficient in the stimulation of autologous EBV-LCL primed T cells.
    Mandell RB; Hank JA; Chen BP; Robins HI; Sondel PM
    Hum Immunol; 1987 Jul; 19(3):163-77. PubMed ID: 3040644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigen.
    Misko IS; Schmidt C; Honeyman M; Soszynski TD; Sculley TB; Burrows SR; Moss DJ; Burman K
    Clin Exp Immunol; 1992 Jan; 87(1):65-70. PubMed ID: 1370774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presentation of soluble antigen to human T cells by products of multiple HLA-linked loci: analysis of antigen presentation by a panel of cloned, autologous, HLA-mutant Epstein-Barr virus-transformed lymphoblastoid cell lines.
    Chen BP; DeMars R; Sondel PM
    Hum Immunol; 1987 Jan; 18(1):75-91. PubMed ID: 3542914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proliferative immune response to autologous Epstein-Barr virus transformed lymphoblastoid cells. II. Studies with HLA class II loss variants demonstrate a role for gene products other than DR and DQ.
    Reitnauer PJ; DeMars R; Sondel PM
    Hum Immunol; 1986 Jul; 16(3):276-88. PubMed ID: 3013814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCL) as stimulating cells in mixed lymphocyte culture (MLC).
    Wasik M; Matej H; Duś D; Myc A
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):879-85. PubMed ID: 6331341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of allogeneic restriction of human cytotoxic T cell clones specific for Epstein Barr virus.
    Tanaka Y; Sugamura K; Hinuma Y
    J Immunol; 1982 Mar; 128(3):1241-5. PubMed ID: 6173428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ proliferative T-cell clones reactive to autologous Epstein-Barr virus-transformed B cells (EBV-LCL) can be restricted by HLA class I molecules.
    Chen BP; DeMars R; Hank JA; Sondel PM
    Cell Immunol; 1988 Sep; 115(2):363-72. PubMed ID: 2842068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of autologous lymphoblastoid cells by cloned human T cells: inhibition of cytotoxicity by anti-HLA antibody but not by antibody to Epstein-Barr virus induced cell surface antigen.
    Hank JA; Sondel PM
    Hum Immunol; 1984 Apr; 9(4):211-9. PubMed ID: 6201468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro induction of HLA-restricted cytotoxic T lymphocytes against autologous Epstein-Barr Virus transformed B lymphoblastoid cell line.
    Fukukawa T; Hirano T; Sakaguchi N; Teranishi T; Tsuyuguchi I; Nagao N; Naito N; Yoshimura K; Okubo Y; Tohda H; Oikawa A
    J Immunol; 1981 May; 126(5):1697-701. PubMed ID: 6163815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
    Nolte A; Buhmann R; Straka C; Emmerich B; Hallek M
    Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
    Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
    J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-induced lymphoblastoid cell lines from seropositive adult donors and their HLA-antigens.
    Akiyama N; Ohsawa N; Kusaba R; Inou T; Takada M
    Jpn J Exp Med; 1981 Feb; 51(1):1-7. PubMed ID: 6273617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of human cytotoxic T-cell lines specific for Epstein-Barr virus-transformed autologous cells.
    Sugamura K; Tanaka Y; Hinuma Y
    Int J Cancer; 1981 Aug; 28(2):137-42. PubMed ID: 6274810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP.
    Lam V; DeMars R; Chen BP; Hank JA; Kovats S; Fisch P; Sondel PM
    J Immunol; 1990 Jul; 145(1):36-45. PubMed ID: 1694208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
    Masucci MG; Torsteindottir S; Colombani J; Brautbar C; Klein E; Klein G
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4567-71. PubMed ID: 3037521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of Epstein-Barr virus (EBV)-infected cells by T cell colonies from a human chimera: restriction by allogeneic determinants.
    Plotnicky H; Touraine JL
    Clin Exp Immunol; 1993 Dec; 94(3):494-9. PubMed ID: 7504600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response to alien histocompatibility antigens on Epstein-Barr virus transformed cells.
    Mori T; Koishi T; Fujii G; Ohsawa N
    Jpn J Exp Med; 1982 Jun; 52(3):125-9. PubMed ID: 6290715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-D typing using Epstein-Barr virus-induced lymphoblastoid cell lines.
    Akiyama N; Ohsawa N; Samaru Y; Kusaba R
    Jpn J Exp Med; 1982 Apr; 52(2):67-73. PubMed ID: 6288983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
    Hill AB; Lee SP; Haurum JS; Murray N; Yao QY; Rowe M; Signoret N; Rickinson AB; McMichael AJ
    J Exp Med; 1995 Jun; 181(6):2221-8. PubMed ID: 7539044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.